Kuano Patents

Patent portfolio assigned to Kuano (verified via public assignee records). Estimated patent count: 1. UK biotech (founded 2020) combining quantum simulation + AI + medicinal chemistry to design enzyme inhibitors. Confirmed patent assignee Kuano Ltd on US20220383992A1 (ML methods of analysing drug-like molecules). Onco-Innovations is a confirmed collaboration partner (PNKP inhibitor optimization). Competitors are quantum/AI drug-discovery peers.